Correlation Between Tempest Therapeutics and Scpharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Scpharmaceuticals, you can compare the effects of market volatilities on Tempest Therapeutics and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Scpharmaceuticals.
Diversification Opportunities for Tempest Therapeutics and Scpharmaceuticals
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Tempest and Scpharmaceuticals is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Scpharmaceuticals go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Scpharmaceuticals
Given the investment horizon of 90 days Tempest Therapeutics is expected to generate 2.44 times more return on investment than Scpharmaceuticals. However, Tempest Therapeutics is 2.44 times more volatile than Scpharmaceuticals. It trades about 0.26 of its potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 72.00 in Tempest Therapeutics on October 20, 2024 and sell it today you would earn a total of 21.00 from holding Tempest Therapeutics or generate 29.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Tempest Therapeutics vs. Scpharmaceuticals
Performance |
Timeline |
Tempest Therapeutics |
Scpharmaceuticals |
Tempest Therapeutics and Scpharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tempest Therapeutics and Scpharmaceuticals
The main advantage of trading using opposite Tempest Therapeutics and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |